Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.
about
Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular riskDalcetrapib: a review of Phase II data.CETP inhibitors and cardiovascular disease: Time to think again.Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.Lipid exchange mechanism of the cholesteryl ester transfer protein clarified by atomistic and coarse-grained simulationsHuman HDL containing a novel apoC-I isoform induces smooth muscle cell apoptosis.Cardiovascular and cancer events in hyper-high-density lipoprotein cholesterolemic patients: a post hoc analysis of the MEGA study.Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community.Identification of genes contributing to cardiovascular disease in overweight and obese individuals from West VirginiaMedical angioplasty - hope and expectations: an optimistic overview.Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.Resequencing of the CETP gene in American whites and African blacks: Association of rare and common variants with HDL-cholesterol levelsNew molecular insights into CETP structure and function: a review.Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart StudyFarnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic miceDyslipidemia and the Risk of Developing Hypertension in a Working-Age Male PopulationElevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism.High-density lipoproteins and cardiovascular disease: 2010 update.Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.Cholesteryl ester transfer protein: the controversial relation to atherosclerosis and emerging new biological roles.CETP Inhibition: does the future look promising?Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention.Emerging therapeutic strategies to enhance HDL function.New horizons for cholesterol ester transfer protein inhibitors.On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.Evacetrapib.Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study.HDL cholesterol and cardiovascular outcomes: what is the evidence?Pharmacotherapies for lipid modification: beyond the statins.HDL: to treat or not to treat?Promising new therapies for the treatment of hypercholesterolemia.The controversy over the use of cholesteryl ester transfer protein inhibitors: is there some light at the end of the tunnel?CETP Inhibition in CVD Prevention: an Actual Appraisal.Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein.Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female miceEffect of evacetrapib on cardiovascular outcomes in patients with high-risk cardiovascular disease.The DEFINE study: a bright future for CETP inhibitors?Decreased cholesterol efflux capacity in patients with low cholesteryl ester transfer protein plasma levelsGenetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease
P2860
Q28731522-F8E40339-9AB6-4F91-AB0C-1C53C693BDBAQ33577236-13B74302-8A57-417D-B987-9358F6BD24BBQ34109100-65A7BF76-E6D0-405E-8EE4-CBB07A1E35BFQ34120778-7ADA2C3C-E54B-41C6-A53D-0B9F266ADF3FQ34130158-5DDCE032-EB48-4744-AA2D-D90DB10E9F55Q34564734-6BC1D394-25A1-4678-8902-692113007B02Q34581693-DFB42A58-A1B3-4326-90F5-D447A243073BQ35485969-4D5A2977-C7BC-448B-B9ED-3EADEE2E90ABQ35608510-5D2871AF-1AB8-426D-962F-092E92DDF661Q35610914-C1EFC0D8-08D7-48EC-B376-8CBDAAEA0AACQ35715349-36F16D49-252F-4DCE-875F-7C523185FDD9Q36386737-AC8BDD75-DA99-45FC-972E-52D57622B776Q36520363-2ACAB0F8-C23D-47CE-8D35-655D1EDAFB66Q36573908-2C186B7B-8F12-456D-9E0C-2675C8929680Q36953767-9F56FE6A-783F-4498-825C-F487C20BFFA8Q37002680-C36C9474-5B02-43C7-B54C-8BDE7EBD59F7Q37090846-8D03DFE7-24EB-4ECD-A127-D42C7EE42B4EQ37340732-53E6E6DA-7659-43B5-9960-4623B979884BQ37707412-4493A2B4-B260-4EEE-AEEB-7391BEF35682Q37774393-B94118AE-7537-4510-80C0-BD3625D33A61Q37864609-A4CE33CA-7E45-4743-8344-A0B56AF8BC58Q37930463-8427D667-24E9-4665-8B78-0536B1FD90CDQ37941053-F8713794-4EFC-4105-A519-835F6A6C5938Q37943857-DC81B5D3-0E17-4484-A49C-46B1FEE61A00Q37956122-C98CAF00-168A-497A-AF12-CABAC18CA231Q37987207-BE6CC422-C060-4BE9-92E6-D186FA924AF0Q37987837-95248CDC-B0EC-4F9B-940B-F731B42414F5Q38048831-3EDC2B07-9E92-4D42-A977-B91A477CF81AQ38082718-88BB93DE-4846-4EC5-B0E1-92386444D064Q38130111-A75C0CDE-4444-4369-B9FD-50315BF47882Q38217089-DFAB8183-6D0F-46A7-B66F-3B237BFA2E30Q38715252-6AA4FD69-DAD4-46E0-8BDC-07C6852D27C3Q38780552-29AC0203-D63C-4249-87DC-CABCECA4D412Q38784639-CD96DDEE-C297-4489-880C-7A579A5DED48Q39016597-00C75C20-F90D-4475-9582-E2A68C84EA43Q41826140-72CFC2BD-06BE-4CE4-8180-5B778D4E480BQ42342025-AE20F2CE-548B-457A-B121-B91F5E65784CQ43439911-E0B71EB7-CE2B-4704-A8C3-204855C3A8C4Q57315966-CE1C1F9C-0456-4D88-8336-CA092BA7BEEFQ58701994-76827CD6-CC0E-443A-ACA8-2F563A11DAC6
P2860
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Association of circulating cho ...... ular disease in the community.
@ast
Association of circulating cho ...... ular disease in the community.
@en
type
label
Association of circulating cho ...... ular disease in the community.
@ast
Association of circulating cho ...... ular disease in the community.
@en
prefLabel
Association of circulating cho ...... ular disease in the community.
@ast
Association of circulating cho ...... ular disease in the community.
@en
P2093
P2860
P50
P1433
P1476
Association of circulating cho ...... ular disease in the community.
@en
P2093
Guneet Kaur
Justin P Zachariah
Ralph B D'Agostino
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.872705
P407
P577
2009-12-01T00:00:00Z